CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 65 filers reported holding CATALYST BIOSCIENCES INC in Q4 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $4,110,000 | -5.1% | 1,000,000 | 0.0% | 1.20% | +1.0% |
Q2 2021 | $4,330,000 | -14.1% | 1,000,000 | 0.0% | 1.19% | +0.4% |
Q1 2021 | $5,040,000 | +521.5% | 1,000,000 | +900.0% | 1.18% | +459.0% |
Q1 2019 | $811,000 | -48.6% | 100,000 | -50.0% | 0.21% | -63.0% |
Q4 2018 | $1,578,000 | -26.8% | 200,000 | 0.0% | 0.57% | +25.1% |
Q3 2018 | $2,156,000 | -48.0% | 200,000 | -43.7% | 0.46% | -62.4% |
Q2 2018 | $4,143,000 | -64.3% | 355,000 | -21.1% | 1.22% | -48.1% |
Q1 2018 | $11,610,000 | – | 450,000 | – | 2.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 471,448 | $5,502,000 | 3.04% |
ACUTA CAPITAL PARTNERS, LLC | 830,000 | $9,686,000 | 1.72% |
NEXTHERA CAPITAL LP | 786,865 | $9,183,000 | 1.42% |
Ghost Tree Capital, LLC | 355,000 | $4,143,000 | 1.22% |
Point72 Europe (London) LLP | 83,500 | $974,000 | 0.52% |
Virtus ETF Advisers LLC | 31,061 | $362,000 | 0.32% |
Eventide Asset Management | 246,000 | $2,871,000 | 0.12% |
Kalos Management, Inc. | 8,500 | $244,000 | 0.11% |
MARSHALL WACE, LLP | 550,352 | $6,423,000 | 0.10% |
GSA CAPITAL PARTNERS LLP | 157,145 | $1,834,000 | 0.09% |